Stallergenes Greer

About:

Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the diagnosis and treatment of allergies.

Website: http://stallergenesgreer.com/

Twitter/X: stallergenescom

Description:

Stallergenes Greer is a global biopharmaceutical company specializing in the diagnosis and treatment of respiratory allergies through the development and commercialization of Allergy Immunotherapy products and services. Our purpose is to enable people with allergies to live normal lives. With more than 1,400 employees worldwide, a presence in 75 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer plc is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France).

Total Funding Amount:

50M EUR

Estimated Revenue Range:

$10B+

Headquarters Location:

London, England, United Kingdom

Founded Date:

2015-01-01

Founders:

R.T. Greer

Number of Employees:

1001-5000

Last Funding Date:

2016-12-01

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai